Yüklüyor......
Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for the Treatment of Major Depressive Disorder:A Systematic Review of Clinical Trials
OBJECTIVE: Desvenlafaxine is the third serotonin-norepinephrine reuptake inhibitor (SNRI) approved by the US Food and Drug Administration for major depressive disorder (MDD). This article summarizes data on the clinical pharmacology, efficacy, safety, and tolerability of desvenlafaxine (administered...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Physicians Postgraduate Press, Inc.
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2947544/ https://ncbi.nlm.nih.gov/pubmed/20944767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.09r00845blu |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|